国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (9): 1459-1464.DOI: 10.3760/cma.j.issn.1007-1245.2024.09.012

• 论著 • 上一篇    下一篇

急性大动脉粥样硬化型脑梗死患者血清CTRP5水平的相关性分析

散丹1  李自如2  袁军2   

  1. 1内蒙古医科大学内蒙古临床医学院,呼和浩特 010000;2内蒙古自治区人民医院神经内科,呼和浩特 010000

  • 收稿日期:2023-12-19 出版日期:2024-05-01 发布日期:2024-05-30
  • 通讯作者: 袁军,Email:13947108585@139.com
  • 基金资助:

    2022年度自治区卫生健康科技计划(202201043)

Correlation of serum CTRP 5 level in patients with acute large artery atherosclerotic cerebral infarction 

San Dan1, Li Ziru2, Yuan Jun2   

  1. 1 Cinical Medical College, Inner Mongolia Medical University, Hohhot 010000, China; 2 Department of Neurology, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010000, China

  • Received:2023-12-19 Online:2024-05-01 Published:2024-05-30
  • Contact: Yuan Jun, Email: 13947108585@139.com
  • Supported by:

    Plan of Health Science and Technology in Inner Mongolia Autonomous Region in 2022 (202201043)

摘要:

目的 探究血清补体C1q关联的肿瘤坏死因子相关蛋白5(CTRP5)水平在急性大动脉粥样硬化(ALAA)型脑梗死患者病程中的血清表达水平及其潜在关联性特征。方法 前瞻性研究,选取2022年12月至2023年8月在内蒙古自治区人民医院住院的112例首次发病ALAA型脑梗死患者[ALAA型脑梗死组,男69例,女43例,年龄(64.25±9.42)岁],并配以55例虽有颅内外大动脉粥样硬化却未表现出脑梗死症状患者[大动脉粥样硬化(LAA)型非脑梗死组,男36例,女19例,年龄(66.98±9.78)岁]、41例存在颅内外大动脉斑块患者[斑块组,男18例,女23例,年龄(65.10±7.63)岁]及37名健康体检者[正常组,男18例,女19例,年龄(63.03±10.85)岁]。通过酶联免疫吸附法(ELISA),测定所有入组人员的血清CTRP5水平,比较ALAA型脑梗死组、非脑梗死对照组(包括斑块组和正常组)之间血清CTRP5水平。统计学方法采用t检验、非参数U检验、χ2检验。结果 正常组与其他3组(即ALAA型脑梗死组、LAA型非脑梗死组以及斑块组)、斑块组与脑梗死组、斑块组与非脑梗死组之间血清CTRP5水平比较,差异均有统计学意义(F=5 259.50、538.00、5 327.00、51 466.50、5 441.00,均P<0.05)。经logistic回归分析,CTRP5水平与患病风险间存在正相关联系(OR值为0.002,95%CI 0~0.171)。CTRP5的受试者操作特征曲线(ROC)分析中得出,ROC曲线下面积为0.937,95%CI 0.895~0.980,证明了CTRP5在鉴别ALAA型脑梗死病例方面具备一定的有效性和准确性。结论 血清CTRP5水平与ALAA型脑梗死及大动脉粥样硬化有一定相关性;并未检测到血清CTRP5水平与神经功能缺损的严重程度之间存在明显的关联关系;血清中CTRP5水平有望成为预测ALAA型脑梗死以及评估大动脉粥样硬化风险的一种潜在生物标志物。

关键词:

急性大动脉粥样硬化, 补体C1q关联的肿瘤坏死因子相关蛋白5, 酶联免疫吸附法, 相关性分析

Abstract:

Objective To explore the serum level of tumor necrosis factor-associated protein 5 (CTRP 5) in the course of patients with acute large atherosclerosis (ALAA) type cerebral infarction and its potential associations. Methods This was a prospective study. One hundred and twelve patients with ALAA cerebral infarction who were hospitalized in Inner Mongolia Autonomous Region People's Hospital from December 2022 to August 2023 were selected as an ALAA cerebral infarction group, including 69 men and 43 women who were (64.25±9.42) years old. Fifty-five control individuals who had intracranial and external intracranial large artery atherosclerosis but no symptoms of cerebral infarction were selected as an LAA non-cerebral infarction group, including 36 men and 19 women who were (66.98±9.78) years old. Forty-one patients with large intracranial artery plaque were selected as a plaque group, including 18 men and 23 women who were (65.10±7.63) years old. Thirty-seven healthy subjects were selected as a normal group, including 18 men and 19 women who were (63.03±10.85) years old. The enzyme-linked immunosorbent assay (ELISA) was used to detect the serum CTRP 5 levels in all the participants. The serum CTRP 5 levels were compared between the ALAA cerebral infarction group and the non-cerebral infarction control groups (including the plaque group and the normal group). t test, nonparametric U test, and χ2 test were used. Results The serum CTRP 5 levels between the normal group and the other 3 groups (the ALAA cerebral infarction group, the LAA non-cerebral infarction group, and the plaque group), between the plaque group and the cerebral infarction group, and between the plaque group and the non-cerebral infarction group were statistically significant (F=5 259.50, 538.00, 5 327.00, 51 466.50, and 5 441.00; all P<0.05). The logistic regression analysis showed that the CTRP 5 level was positively correlated with the disease risk (OR=0.002, 95%CI 0-0.171). The ROC analysis of CTRP 5 showed that the area under the ROC was 0.937 (95%CI 0.895-0.980), demonstrating the effectiveness and accuracy of CTRP 5 in identifying cases of ALAA cerebral infarction. Conclusions There is some correlation between serum CTRP 5 level and ALAA cerebral infarction and major atherosclerosis. No clear association is detected between serum CTRP 5 level and severity of neurological deficit. CTRP 5 level in serum is expected to be a potential biomarker for predicting ALAA cerebral infarction and assessing the risk of major atherosclerosis.

Key words:

Acute large artery atherosclerosis, Immunocomplement / C1q tumor necrosis factor-related protein 5, Enzyme-linked immunosorbent method, Analysis of correlation